Fibromyalgia Therapeutics Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Drug class (Antidepressants, Anticonvulsants, Analgesics, Muscle Relaxants); Distribution channels (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies), and geography

Code: RW00013949137
The Insight Partners
May-2021
Life Sciences
150 Pages

MARKET INTRODUCTION

Fibromyalgia is a disease characterized by widespread musculoskeletal pain followed by problems with tiredness, sleep, memory and mood. Researchers conclude that fibromyalgia amplifies painful sensations by influencing how painful and non-painful impulses are interpreted by the brain and spinal cord. The pain of fibromyalgia can be relieved by certain prescription drugs. Before they find the right combination for them, people with fibromyalgia may need to try multiple medications or different dosages.

MARKET DYNAMICS

Factors driving the growth of the fibromyalgia therapeutics market are the growing number of trauma cases and surgeries, coupled with rising geriatric population worldwide. However, the lower the diagnosis rate of patients having fibromyalgia is expected to hamper the growth of the market. Moreover, increasing prevalence of fibromyalgia and rising road accidents is anticipated to boost the market growth.

MARKET SCOPE

The "Fibromyalgia Therapeutics Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of fibromyalgia therapeutics market with detailed market segmentation by product type, raw material, application and end user. The fibromyalgia therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in fibromyalgia therapeutics market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The fibromyalgia therapeutics market is segmented on the basis of drug class and distribution channels. Based on drug class, the market is segmented as antidepressants, anticonvulsants, analgesics, and muscle relaxants. Antidepressants are sub segmented as Venlafaxine, Duloxetine HCl, Milnacipran HCl, and Others. Anticonvulsants are sub segmented as pregabalin, gabapentin, and others. On the basis of distribution channels, the market is categorized as hospitals pharmacies, retail pharmacies, and online pharmacies.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Fibromyalgia Therapeutics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Fibromyalgia Therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Fibromyalgia Therapeutics market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Fibromyalgia Therapeutics market in these regions.

MARKET PLAYERS

The report covers key developments in the Fibromyalgia Therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Fibromyalgia Therapeutics market are anticipated to have lucrative growth opportunities in the future with the rising demand for Fibromyalgia Therapeutics in the global market. Below mentioned is the list of few companies engaged in the Fibromyalgia Therapeutics market.

The report also includes the profiles of key players in Fibromyalgia Therapeutics market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

Daiichi Sankyo
Eli Lilly
Innovative Med Concepts
Pfizer
Theravance Biopharma
Forest Pharmaceuticals, Inc.
Innovative Med Concepts
Meiji Seika Pharma
Tonix Pharmaceuticals
Aptinyx, Inc.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Fibromyalgia Therapeutics Market - By Drug class
1.3.2 Fibromyalgia Therapeutics Market - By Distribution channels
1.3.3 Fibromyalgia Therapeutics Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. FIBROMYALGIA THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. FIBROMYALGIA THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. FIBROMYALGIA THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. FIBROMYALGIA THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. FIBROMYALGIA THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. FIBROMYALGIA THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. ANTIDEPRESSANTS
7.3.1. Overview
7.3.2. Antidepressants Market Forecast and Analysis
7.3.3. Venlafaxine Market
7.3.3.1. Overview
7.3.3.2. Venlafaxine Market Forecast and Analysis
7.3.4. Duloxetine HCl Market
7.3.4.1. Overview
7.3.4.2. Duloxetine HCl Market Forecast and Analysis
7.3.5. Milnacipran HCl Market
7.3.5.1. Overview
7.3.5.2. Milnacipran HCl Market Forecast and Analysis
7.3.6. Others Market
7.3.6.1. Overview
7.3.6.2. Others Market Forecast and Analysis
7.4. ANTICONVULSANTS
7.4.1. Overview
7.4.2. Anticonvulsants Market Forecast and Analysis
7.4.3. Pregabalin Market
7.4.3.1. Overview
7.4.3.2. Pregabalin Market Forecast and Analysis
7.4.4. Gabapentin Market
7.4.4.1. Overview
7.4.4.2. Gabapentin Market Forecast and Analysis
7.4.5. Others Market
7.4.5.1. Overview
7.4.5.2. Others Market Forecast and Analysis
7.5. ANALGESICS
7.5.1. Overview
7.5.2. Analgesics Market Forecast and Analysis
7.6. MUSCLE RELAXANTS
7.6.1. Overview
7.6.2. Muscle Relaxants Market Forecast and Analysis
8. FIBROMYALGIA THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNELS
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNELS MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS PHARMACIES
8.3.1. Overview
8.3.2. Hospitals Pharmacies Market Forecast and Analysis
8.4. RETAIL PHARMACIES
8.4.1. Overview
8.4.2. Retail Pharmacies Market Forecast and Analysis
8.5. ONLINE PHARMACIES
8.5.1. Overview
8.5.2. Online Pharmacies Market Forecast and Analysis
9. FIBROMYALGIA THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Fibromyalgia Therapeutics Market Overview
9.1.2 North America Fibromyalgia Therapeutics Market Forecasts and Analysis
9.1.3 North America Fibromyalgia Therapeutics Market Forecasts and Analysis - By Drug class
9.1.4 North America Fibromyalgia Therapeutics Market Forecasts and Analysis - By Distribution channels
9.1.5 North America Fibromyalgia Therapeutics Market Forecasts and Analysis - By Countries
9.1.5.1 United States Fibromyalgia Therapeutics Market
9.1.5.1.1 United States Fibromyalgia Therapeutics Market by Drug class
9.1.5.1.2 United States Fibromyalgia Therapeutics Market by Distribution channels
9.1.5.2 Canada Fibromyalgia Therapeutics Market
9.1.5.2.1 Canada Fibromyalgia Therapeutics Market by Drug class
9.1.5.2.2 Canada Fibromyalgia Therapeutics Market by Distribution channels
9.1.5.3 Mexico Fibromyalgia Therapeutics Market
9.1.5.3.1 Mexico Fibromyalgia Therapeutics Market by Drug class
9.1.5.3.2 Mexico Fibromyalgia Therapeutics Market by Distribution channels
9.2. EUROPE
9.2.1 Europe Fibromyalgia Therapeutics Market Overview
9.2.2 Europe Fibromyalgia Therapeutics Market Forecasts and Analysis
9.2.3 Europe Fibromyalgia Therapeutics Market Forecasts and Analysis - By Drug class
9.2.4 Europe Fibromyalgia Therapeutics Market Forecasts and Analysis - By Distribution channels
9.2.5 Europe Fibromyalgia Therapeutics Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Fibromyalgia Therapeutics Market
9.2.5.1.1 Germany Fibromyalgia Therapeutics Market by Drug class
9.2.5.1.2 Germany Fibromyalgia Therapeutics Market by Distribution channels
9.2.5.2 France Fibromyalgia Therapeutics Market
9.2.5.2.1 France Fibromyalgia Therapeutics Market by Drug class
9.2.5.2.2 France Fibromyalgia Therapeutics Market by Distribution channels
9.2.5.3 Italy Fibromyalgia Therapeutics Market
9.2.5.3.1 Italy Fibromyalgia Therapeutics Market by Drug class
9.2.5.3.2 Italy Fibromyalgia Therapeutics Market by Distribution channels
9.2.5.4 Spain Fibromyalgia Therapeutics Market
9.2.5.4.1 Spain Fibromyalgia Therapeutics Market by Drug class
9.2.5.4.2 Spain Fibromyalgia Therapeutics Market by Distribution channels
9.2.5.5 United Kingdom Fibromyalgia Therapeutics Market
9.2.5.5.1 United Kingdom Fibromyalgia Therapeutics Market by Drug class
9.2.5.5.2 United Kingdom Fibromyalgia Therapeutics Market by Distribution channels
9.2.5.6 Rest of Europe Fibromyalgia Therapeutics Market
9.2.5.6.1 Rest of Europe Fibromyalgia Therapeutics Market by Drug class
9.2.5.6.2 Rest of Europe Fibromyalgia Therapeutics Market by Distribution channels
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Fibromyalgia Therapeutics Market Overview
9.3.2 Asia-Pacific Fibromyalgia Therapeutics Market Forecasts and Analysis
9.3.3 Asia-Pacific Fibromyalgia Therapeutics Market Forecasts and Analysis - By Drug class
9.3.4 Asia-Pacific Fibromyalgia Therapeutics Market Forecasts and Analysis - By Distribution channels
9.3.5 Asia-Pacific Fibromyalgia Therapeutics Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Fibromyalgia Therapeutics Market
9.3.5.1.1 Australia Fibromyalgia Therapeutics Market by Drug class
9.3.5.1.2 Australia Fibromyalgia Therapeutics Market by Distribution channels
9.3.5.2 China Fibromyalgia Therapeutics Market
9.3.5.2.1 China Fibromyalgia Therapeutics Market by Drug class
9.3.5.2.2 China Fibromyalgia Therapeutics Market by Distribution channels
9.3.5.3 India Fibromyalgia Therapeutics Market
9.3.5.3.1 India Fibromyalgia Therapeutics Market by Drug class
9.3.5.3.2 India Fibromyalgia Therapeutics Market by Distribution channels
9.3.5.4 Japan Fibromyalgia Therapeutics Market
9.3.5.4.1 Japan Fibromyalgia Therapeutics Market by Drug class
9.3.5.4.2 Japan Fibromyalgia Therapeutics Market by Distribution channels
9.3.5.5 South Korea Fibromyalgia Therapeutics Market
9.3.5.5.1 South Korea Fibromyalgia Therapeutics Market by Drug class
9.3.5.5.2 South Korea Fibromyalgia Therapeutics Market by Distribution channels
9.3.5.6 Rest of Asia-Pacific Fibromyalgia Therapeutics Market
9.3.5.6.1 Rest of Asia-Pacific Fibromyalgia Therapeutics Market by Drug class
9.3.5.6.2 Rest of Asia-Pacific Fibromyalgia Therapeutics Market by Distribution channels
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Fibromyalgia Therapeutics Market Overview
9.4.2 Middle East and Africa Fibromyalgia Therapeutics Market Forecasts and Analysis
9.4.3 Middle East and Africa Fibromyalgia Therapeutics Market Forecasts and Analysis - By Drug class
9.4.4 Middle East and Africa Fibromyalgia Therapeutics Market Forecasts and Analysis - By Distribution channels
9.4.5 Middle East and Africa Fibromyalgia Therapeutics Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Fibromyalgia Therapeutics Market
9.4.5.1.1 South Africa Fibromyalgia Therapeutics Market by Drug class
9.4.5.1.2 South Africa Fibromyalgia Therapeutics Market by Distribution channels
9.4.5.2 Saudi Arabia Fibromyalgia Therapeutics Market
9.4.5.2.1 Saudi Arabia Fibromyalgia Therapeutics Market by Drug class
9.4.5.2.2 Saudi Arabia Fibromyalgia Therapeutics Market by Distribution channels
9.4.5.3 U.A.E Fibromyalgia Therapeutics Market
9.4.5.3.1 U.A.E Fibromyalgia Therapeutics Market by Drug class
9.4.5.3.2 U.A.E Fibromyalgia Therapeutics Market by Distribution channels
9.4.5.4 Rest of Middle East and Africa Fibromyalgia Therapeutics Market
9.4.5.4.1 Rest of Middle East and Africa Fibromyalgia Therapeutics Market by Drug class
9.4.5.4.2 Rest of Middle East and Africa Fibromyalgia Therapeutics Market by Distribution channels
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Fibromyalgia Therapeutics Market Overview
9.5.2 South and Central America Fibromyalgia Therapeutics Market Forecasts and Analysis
9.5.3 South and Central America Fibromyalgia Therapeutics Market Forecasts and Analysis - By Drug class
9.5.4 South and Central America Fibromyalgia Therapeutics Market Forecasts and Analysis - By Distribution channels
9.5.5 South and Central America Fibromyalgia Therapeutics Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Fibromyalgia Therapeutics Market
9.5.5.1.1 Brazil Fibromyalgia Therapeutics Market by Drug class
9.5.5.1.2 Brazil Fibromyalgia Therapeutics Market by Distribution channels
9.5.5.2 Argentina Fibromyalgia Therapeutics Market
9.5.5.2.1 Argentina Fibromyalgia Therapeutics Market by Drug class
9.5.5.2.2 Argentina Fibromyalgia Therapeutics Market by Distribution channels
9.5.5.3 Rest of South and Central America Fibromyalgia Therapeutics Market
9.5.5.3.1 Rest of South and Central America Fibromyalgia Therapeutics Market by Drug class
9.5.5.3.2 Rest of South and Central America Fibromyalgia Therapeutics Market by Distribution channels
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL FIBROMYALGIA THERAPEUTICS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. FIBROMYALGIA THERAPEUTICS MARKET, KEY COMPANY PROFILES
12.1. DAIICHI SANKYO
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ELI LILLY
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. INNOVATIVE MED CONCEPTS
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. PFIZER
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. THERAVANCE BIOPHARMA
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. FOREST PHARMACEUTICALS, INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. INNOVATIVE MED CONCEPTS
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. MEIJI SEIKA PHARMA
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. TONIX PHARMACEUTICALS
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. APTINYX, INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS

The List of Companies

1. Daiichi Sankyo
2. Eli Lilly
3. Innovative Med Concepts
4. Pfizer
5. Theravance Biopharma
6. Forest Pharmaceuticals, Inc.
7. Innovative Med Concepts
8. Meiji Seika Pharma
9. Tonix Pharmaceuticals
10. Aptinyx, Inc.

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Altapharma Market Growth 2021-202.. According to this latest study, the 2020 growth of Altapharm..

Global Autogenous Vaccines Market Growth.. According to this latest study, the 2020 growth of Autogenou..

Global Single Use Cystoscope Market Grow.. According to this latest study, the 2020 growth of Single Us..

Global Orthopedic Veterinary Implants Ma.. According to this latest study, the 2020 growth of Orthopedi..

Global Ultrasound Conductivity Gel Marke.. According to this latest study, the 2020 growth of Ultrasoun..

Global Single Sided Cloth Tapes Market G.. According to this latest study, the 2020 growth of Single Si..

Global Medical Transfer Tapes Market Gro.. According to this latest study, the 2020 growth of Medical T..

Global Honeysuckle Essential Oil Market .. According to this latest study, the 2020 growth of Honeysuck..

Global Double-coated Medical Tapes Marke.. According to this latest study, the 2020 growth of Double-co..

Global Coil Assisted Flow Diverters Mark.. According to this latest study, the 2020 growth of Coil Assi..

Global IV Fluid Warmer Market Growth 202.. According to this latest study, the 2020 growth of IV Fluid ..

Global Polyethylene IV Bags Market Growt.. According to this latest study, the 2020 growth of Polyethyl..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE